NO934098D0 - Galaninantagonist - Google Patents

Galaninantagonist

Info

Publication number: NO934098D0
Authority: NO; Norway
Prior art keywords: galanin; pro; enkephalin; leu; antagonist
Prior art date: 1991-05-15

Application number

NO1993934098A

Other languages

English (en)

Norwegian (no)

Other versions

NO934098L (no

Inventor

Tamas Bartfai

Tomas Hoekfelt

Ulo Langel

Bo Ahren

Stefan Lindskog

Silvana Consolo

Tiit Land

Zsuzsanna Wiesenfeld-Hallin

Original Assignee

Astra Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-05-15

Filing date

1993-11-12

Publication date

1993-11-12

1993-11-12 Application filed by Astra Ab filed Critical Astra Ab

1993-11-12 Publication of NO934098L publication Critical patent/NO934098L/no

1993-11-12 Publication of NO934098D0 publication Critical patent/NO934098D0/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/70—Enkephalins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/18—Kallidins; Bradykinins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurology (AREA)
General Chemical & Material Sciences (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Endocrinology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Saccharide Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO1993934098A 1991-05-15 1993-11-12 Galaninantagonist NO934098D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9101472A SE9101472D0 (sv)	1991-05-15	1991-05-15	Galanin antagonist
PCT/SE1992/000316 WO1992020709A1 (en)	1991-05-15	1992-05-14	Galanin antagonist

Publications (2)

Publication Number	Publication Date
NO934098L NO934098L (no)	1993-11-12
NO934098D0 true NO934098D0 (no)	1993-11-12

Family

ID=20382742

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO1993934098A NO934098D0 (no)	1991-05-15	1993-11-12	Galaninantagonist

Country Status (24)

Country	Link
EP (2)	EP0585300B1 (de)
JP (1)	JPH06507629A (de)
KR (1)	KR100221769B1 (de)
AT (1)	ATE149525T1 (de)
AU (1)	AU664180B2 (de)
CA (1)	CA2109503A1 (de)
CZ (1)	CZ242293A3 (de)
DE (2)	DE69217937T2 (de)
DK (1)	DK0585300T3 (de)
EE (1)	EE9400346A (de)
ES (1)	ES2098510T3 (de)
FI (1)	FI935010L (de)
GR (1)	GR3023150T3 (de)
HU (1)	HUT65810A (de)
IE (1)	IE921555A1 (de)
IS (1)	IS3866A (de)
NO (1)	NO934098D0 (de)
PL (1)	PL171497B1 (de)
SE (1)	SE9101472D0 (de)
SG (1)	SG43921A1 (de)
SI (1)	SI9200081B (de)
SK (1)	SK127793A3 (de)
WO (1)	WO1992020709A1 (de)
YU (1)	YU50592A (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL107400A0 (en) *	1992-11-10	1994-01-25	Cortech Inc	Bradykinin antagonists
FR2716205B1 (fr)	1994-02-17	1996-04-12	Rhone Poulenc Rorer Sa	Récepteur galanine, acides nucléiques, cellules transformées et utilisations.
US6790656B1 (en)	1996-01-24	2004-09-14	Synaptic Pharmaceutical Corporation	DNA encoding galanin GALR2 receptors
US5972624A (en) *	1996-01-24	1999-10-26	Synaptic Pharmaceutical Corporation	Method of identifying ligands which bind recombinant galanin receptor (GALR2)
EP0918455B1 (de)	1996-07-24	2003-04-16	Neurotargets Limited	Gebrauch von galanin um nervenschäden zu reparieren
US6329197B2 (en)	1996-10-09	2001-12-11	Synaptic Pharmaceutical Corporation	DNA encoding galanin GALR3 receptors and uses thereof
AU741546B2 (en) *	1997-07-24	2001-12-06	Perseptive Biosystems, Inc.	Conjugates of transporter peptides and nucleic acid analogs, and their use
WO1999048920A1 (en) *	1998-03-25	1999-09-30	Takeda Chemical Industries, Ltd.	Novel physiologically active peptides and utilization thereof
US6407136B1 (en)	1999-05-21	2002-06-18	Ortho-Mcneil Pharmaceutical, Inc.	1,4-dithiin and 1,4-dithiepin-1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor
WO2000071533A2 (en) *	1999-05-21	2000-11-30	Ortho-Mcneil Pharmaceutical, Inc.	1,4-dithiin and 1,4-dithiepin- 1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor
EP1089439A1 (de) *	1999-09-28	2001-04-04	TELEFONAKTIEBOLAGET L M ERICSSON (publ)	Verschachteler und Eingangsdatabitverschachtelungsverfahren unter Anwendung von symbolkodierter Speicherung und zusätzlichen Informationen
US7220775B2 (en)	2002-08-07	2007-05-22	H. Lundbeck A/S	Compound useful for the treatment of neuropathic pain
EP1809619A1 (de)	2004-10-21	2007-07-25	Transtech Pharma, Inc.	Bisulfonamidverbindungen als agonisten von galr1, zusammensetzungen daraus und verwendungsmöglichkeiten dafür
GB0523550D0 (en)	2005-11-18	2005-12-28	Hunter Fleming Ltd	Therapeutic uses of steroidal compounds
KR20090009189A (ko)	2006-01-05	2009-01-22	유니버시티 오브 유타 리써치 파운데이션	신경계를 표적으로 하는 약제학적 제제의 특성 향상 방법및 특성 향상용 조성물
US20100204129A1 (en) *	2008-09-09	2010-08-12	Dorian Bevec	Use of a peptide as a therapeutic agent
WO2012082942A2 (en)	2010-12-15	2012-06-21	Neuroadjuvants, Inc.	Neuropeptide analogs, compositions, and methods for treating pain
US10450343B2 (en)	2013-03-21	2019-10-22	Sanofi-Aventis Deutschland Gmbh	Synthesis of cyclic imide containing peptide products
HUE034308T2 (en)	2013-03-21	2018-02-28	Sanofi Aventis Deutschland	Preparation of hydantoin-containing peptide products
CN110055340B (zh) *	2019-04-11	2021-01-01	中国农业大学	一种食品中牛源成分快速检测方法及试剂盒

1991
- 1991-05-15 SE SE9101472A patent/SE9101472D0/xx unknown
1992
- 1992-05-13 YU YU50592A patent/YU50592A/sh unknown
- 1992-05-14 CZ CS932422A patent/CZ242293A3/cs unknown
- 1992-05-14 FI FI935010A patent/FI935010L/fi unknown
- 1992-05-14 SG SG1996005509A patent/SG43921A1/en unknown
- 1992-05-14 PL PL92301284A patent/PL171497B1/pl unknown
- 1992-05-14 JP JP4510575A patent/JPH06507629A/ja active Pending
- 1992-05-14 EP EP92910508A patent/EP0585300B1/de not_active Expired - Lifetime
- 1992-05-14 AT AT92910508T patent/ATE149525T1/de not_active IP Right Cessation
- 1992-05-14 DE DE69217937T patent/DE69217937T2/de not_active Expired - Fee Related
- 1992-05-14 ES ES92910508T patent/ES2098510T3/es not_active Expired - Lifetime
- 1992-05-14 KR KR1019930703433A patent/KR100221769B1/ko not_active Expired - Fee Related
- 1992-05-14 CA CA002109503A patent/CA2109503A1/en not_active Abandoned
- 1992-05-14 SK SK1277-93A patent/SK127793A3/sk unknown
- 1992-05-14 HU HU9303236A patent/HUT65810A/hu unknown
- 1992-05-14 AU AU17858/92A patent/AU664180B2/en not_active Ceased
- 1992-05-14 DE DE0585300T patent/DE585300T1/de active Pending
- 1992-05-14 DK DK92910508.8T patent/DK0585300T3/da active
- 1992-05-14 WO PCT/SE1992/000316 patent/WO1992020709A1/en not_active Ceased
- 1992-05-14 EP EP19920850108 patent/EP0514361A1/de active Pending
- 1992-05-15 SI SI9200081A patent/SI9200081B/sl unknown
- 1992-05-15 IS IS3866A patent/IS3866A/is unknown
- 1992-07-01 IE IE155592A patent/IE921555A1/en unknown
1993
- 1993-11-12 NO NO1993934098A patent/NO934098D0/no not_active Application Discontinuation
1994
- 1994-11-03 EE EE9400346A patent/EE9400346A/xx unknown
1997
- 1997-04-15 GR GR970400812T patent/GR3023150T3/el unknown

Also Published As

Publication number	Publication date
FI935010A0 (fi)	1993-11-12
ATE149525T1 (de)	1997-03-15
IS3866A (is)	1992-11-16
CZ242293A3 (en)	1994-07-13
ES2098510T3 (es)	1997-05-01
EP0585300B1 (de)	1997-03-05
SE9101472D0 (sv)	1991-05-15
KR100221769B1 (ko)	1999-10-01
EP0514361A1 (de)	1992-11-19
HUT65810A (en)	1994-07-28
JPH06507629A (ja)	1994-09-01
YU50592A (sh)	1994-09-09
SI9200081B (sl)	2000-08-31
WO1992020709A1 (en)	1992-11-26
FI935010A7 (fi)	1993-11-12
CA2109503A1 (en)	1992-11-16
SG43921A1 (en)	1997-11-14
PL171497B1 (pl)	1997-05-30
SK127793A3 (en)	1994-04-06
DE69217937T2 (de)	1997-06-19
FI935010L (fi)	1993-11-12
AU664180B2 (en)	1995-11-09
DE69217937D1 (de)	1997-04-10
NO934098L (no)	1993-11-12
IE921555A1 (en)	1992-11-18
EP0585300A1 (de)	1994-03-09
GR3023150T3 (en)	1997-07-30
DE585300T1 (de)	1994-06-16
EE9400346A (et)	1996-04-15
AU1785892A (en)	1992-12-30
DK0585300T3 (da)	1997-09-01
SI9200081A (en)	1992-12-31

Legal Events

Date	Code	Title	Description
2002-03-11	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
DK0585300T3 (da)	1997-09-01	Galaninantagonist
EP1233013A4 (de)	2004-05-12	Phenylalaninderivate
TW349867B (en)	1999-01-11	Pharmaceutical composition for inducing a cytotoxic T-lymphocyte responses
FI910286A0 (fi)	1991-01-18	Analoger av humant insulin och preparat innehaollande dessa.
DE69028671D1 (de)	1996-10-31	Löslisches extrazellulares Fragment des menschlischen IFN-beta 2/IL-6-Rezeptors, seine Herstellung und diesen Fragment enthaltende pharmazeutische Mischung
ATE497385T1 (de)	2011-02-15	Neue phenylalanin-derivate
FI916077A7 (fi)	1991-12-20	Glykosyloimattomia ihmisen interleukiini 3:n proteiinianalogeja
NO960630D0 (no)	1996-02-16	Heterocykler anvendelige som neurokinin antagonister
BR0211186A (pt)	2007-01-30	peptìdeos e uso dos mesmos no escurecimento da pele
AU682638B2 (en)	1997-10-09	Peptide, bronchodilator and blood flow ameliorant
DE69006676D1 (de)	1994-03-24	Tripeptidverbindungen und ihre pharmazeutische Anwendung als Immunmodulatoren.
DE59409140D1 (de)	2000-03-16	Cyclosporin(e) enthaltende o/w Emulsion zur oralen Verabreichung
DE59003456D1 (de)	1993-12-16	Fahrerhaus-Schlafliege-Herausfallsicherung.
ES2162078T3 (es)	2001-12-16	Compuestos terapeuticos.
DE69232771D1 (de)	2002-10-17	Peptide als antagonisten von endothelin
ATE107165T1 (de)	1994-07-15	Verwendung von macrolactonen als antiallergica.
MX9206339A (es)	1993-05-01	Nueva proteina inhibidora de trombina a partir de chinches de monte
RU93058426A (ru)	1996-09-20	Антогонист галанина, способ его получения, пептид, фармацевтический состав и способ лечения
IT8919672A0 (it)	1989-03-07	Perfezionamenti nell'ottenimento di cerotti.
IT8819985A0 (it)	1988-03-28	O_(1,2_di_0_acetilglicero_3_fosforil)etanolamina, procedimento per la sua preparazione e suo uso terapeutico.
ES2060400T3 (es)	1994-11-16	Vinilsulfonil pristinamicina y su preparacion.
NO880831D0 (no)	1988-02-25	Rekombinant human vevsplasminogen-aktivatorblanding.
ITTV950119A0 (it)	1995-10-13	Procedimento per l'esecuzione di un doppio nodo semplice ed apparec- chiatura perfezionata cosi' ottenuta, particolarmente nei processi peril rivestimento di componenti per sedie
ITGE910032A1 (it)	1992-08-11	Metodo e dispositivo per il controllo dell'ammiccamento per uso oftalmologico e di sicurezza per la guida.
IT8922251A0 (it)	1989-11-03	Peptide sintetico derivato dalla lipocortina v umana e suo impiego